Nebulized dexmedetomidine improves pulmonary shunt and lung mechanics during one-lung ventilation: a randomized clinical controlled trial

BACKGROUND: Dexmedetomidine (Dex), a selective a(2)-adrenergic receptor agonist, has been previously reported to attenuate intrapulmonary shunt during one-lung ventilation (OLV) and to alleviate bronchoconstriction. However, the therapeutic effects of nebulized Dex on pulmonary shunt and lung mechan...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Bo, Gao, Hong, Li, Dan, Hu, Chunxiao, Yang, Jianping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2020
Materias:
Anesthesiology and Pain Management
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278887/
https://www.ncbi.nlm.nih.gov/pubmed/32547872
http://dx.doi.org/10.7717/peerj.9247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278887/
https://www.ncbi.nlm.nih.gov/pubmed/32547872
http://dx.doi.org/10.7717/peerj.9247

Ejemplares similares